Clinical Trial Update: Randomized Controlled Trial (RCT)Comparing GYNAECARE MORCELLEX Versus ROTOCUT GI Tissue Morcellators [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing GYNAECARE MORCELLEX and ROTOCUT GI Tissue Morcellators for uterine fibroids has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• GYNAECARE MORCELLEX
• ROTOCUT GI Tissue Morcellators

Snippet

Sponsor: University Magna Graecia | Conditions: Uterine Myomas | Phase 4 | Status: COMPLETED